Prostate Cancer - Results from #20420

Activity and safety of ODM-201 in patients with progressive metastatic castration-resistant prostate cancer (ARADES): An open-label phase 1 dose-escalation and randomised phase 2 dose expansion trial - Abstract August 7, 2014

Non-steroidal antiandrogen monotherapy compared with luteinising hormone-releasing hormone agonists or surgical castration monotherapy for advanced prostate cancer - Abstract August 7, 2014

The association between insurance status and prostate cancer outcomes: Implications for the Affordable Care Act - Abstract August 7, 2014

"It's all very well reading the letters in the genome, but it's a long way to being able to write": Men's interpretations of undergoing genetic profiling to determine future risk of prostate cancer - Abstract August 7, 2014

Screening and prostate cancer mortality: Results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up - Abstract August 6, 2014

Trends in disparate treatment of African American men with localized prostate cancer across National Comprehensive Cancer Network Risk Groups - Abstract August 6, 2014

PSA flare after initiation of abiraterone acetate - Abstract August 6, 2014

The association of long-term treatment-related side effects with cancer-specific and general quality of life among prostate cancer survivors - Abstract August 6, 2014

Head to head comparison of two currently used nomograms predicting the risk of side specific extra capsular extension to indicate nerve sparing during radical prostatectomy for treatment of prostate cancer - Abstract August 6, 2014

Urodynamic evaluation before and immediately after robot-assisted radical prostatectomy - Abstract August 6, 2014

Perineural invasion in prostate cancer patients who are potential candidates for active surveillance: Validation study - Abstract August 6, 2014

Prostate size and adverse pathologic features in men undergoing radical prostatectomy - Abstract August 6, 2014

Total pelvic floor reconstruction during non-nerve-sparing laparoscopic radical prostatectomy: Impact on early recovery of urinary continence - Abstract August 6, 2014

Intensity-modulated pelvic radiation therapy and simultaneous integrated boost to the prostate area in patients with high-risk prostate cancer: A preliminary report of disease control - Abstract August 6, 2014

Prostate cancer and the influence of dietary factors and supplements: A systematic review - Abstract August 6, 2014

Outcomes after radical prostatectomy for cancer: A comparison between general anesthesia and epidural anesthesia with fentanyl analgesia: A matched cohort study - Abstract August 6, 2014

Emerging targets to monitor and overcome docetaxel resistance in castration resistant prostate cancer (Review) - Abstract August 5, 2014

Pharmacologic inhibition of myostatin and changes in lean body mass and lower extremity muscle size in patients receiving androgen deprivation therapy for prostate cancer - Abstract August 5, 2014

Increased risk of pneumonia in patients receiving gonadotropin-releasing hormone agonists for prostate cancer - Abstract August 5, 2014

The prognostic significance of combined ERG and androgen receptor expression in patients with prostate cancer managed by androgen deprivation therapy - Abstract August 5, 2014

Page 1022 of 1458